Palatin Technologies
PTN
#9923
Rank
โ‚ฌ33.63 M
Marketcap
19,75ย โ‚ฌ
Share price
4.59%
Change (1 day)
2,148.55%
Change (1 year)

Palatin Technologies (PTN) - Total debt

Total debt on the balance sheet as of March 2025 : โ‚ฌ0.22 Million

According to Palatin Technologies's latest financial reports the company's total debt is โ‚ฌ0.22 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Palatin Technologies - Total debt on balance sheet (from 1997 to 2025)

Total debt by year

Year Total debt Change
2024-06-30โ‚ฌ0.54 M-42.88%
2023-06-30โ‚ฌ0.96 M-12.58%
2022-06-30โ‚ฌ1.1 M4.26%
2021-06-30โ‚ฌ1.05 M-6.27%
2020-06-30โ‚ฌ1.12 M284.7%
2019-06-30โ‚ฌ0.29 M-94.54%
2018-06-30โ‚ฌ5.36 M-56.63%
2017-06-30โ‚ฌ12.37 M-29.6%
2016-06-30โ‚ฌ17.57 M98.75%
2015-06-30โ‚ฌ8.84 M
2014-06-30N/A-100%
2013-06-30โ‚ฌ0.01 M-54.1%
2012-06-30โ‚ฌ0.03 M-37.34%
2011-06-30โ‚ฌ0.05 M95.93%
2010-06-30โ‚ฌ0.02 M-68.44%
2009-06-30โ‚ฌ0.08 M-64.8%
2008-06-30โ‚ฌ0.24 M-33.25%
2007-06-30โ‚ฌ0.36 M46.65%
2006-06-30โ‚ฌ0.24 M886.38%
2005-06-30โ‚ฌ0.02 M-51.68%
2004-06-30โ‚ฌ0.05 M-77.35%
2003-06-30โ‚ฌ0.23 M
2001-06-30โ‚ฌ0.03 M
1999-06-30โ‚ฌ1.94 M156.09%
1998-06-30โ‚ฌ0.75 M-50%
1997-06-30โ‚ฌ1.51 M-44.71%
1996-06-30โ‚ฌ2.74 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
MediciNova
MNOV
โ‚ฌ0.25 M 15.12%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ0.36 B 163,274.27%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚ฌ0.53 B 236,460.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.38 B 171,891.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ39.33 B 17,464,242.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
โ‚ฌ0.17 B 79,074.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ28.02 B 12,444,412.24%๐Ÿ‡ฌ๐Ÿ‡ง UK